WIN-Partners Co., Ltd. Share Price

Equities

3183

JP3154390003

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 11:30:00 26/04/2024 am IST 5-day change 1st Jan Change
1,167 JPY +0.09% Intraday chart for WIN-Partners Co., Ltd. -1.10% -2.42%

Financials

Sales 2022 66.39B 425M 35.46B Sales 2023 70.85B 453M 37.84B Capitalization 28.87B 185M 15.42B
Net income 2022 1.83B 11.72M 978M Net income 2023 2.05B 13.1M 1.09B EV / Sales 2022 0.19 x
Net cash position 2022 15.57B 99.66M 8.32B Net cash position 2023 16.77B 107M 8.96B EV / Sales 2023 0.17 x
P/E ratio 2022
15.6 x
P/E ratio 2023
14.1 x
Employees 609
Yield 2022
3.5%
Yield 2023
3.54%
Free-Float 52.95%
More Fundamentals * Assessed data
Dynamic Chart
Win-Partners Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Win-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
WIN-Partners Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024 CI
WIN-Partners Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 29, 2023 CI
WIN-Partners Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
WIN-Partners Co., Ltd. intends to acquire Trytech Corporation from MEDIX JAPAN,Inc. CI
WIN-Partners Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023 CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023 CI
Blisspack Co.,Ltd and Win Partners Co., Ltd cancelled the acquisition of 12.74% stake in FN REPUBLIC Co., Ltd from FN Cosmedics Co., Ltd.. CI
Blisspack Co.,Ltd and Win Partners Co., Ltd agreed to acquire 12.74% stake in FN REPUBLIC Co., Ltd from FN Cosmedics Co., Ltd. for KRW 7 billion. CI
WIN-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023 CI
Win-Partners Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023 CI
More news
1 day+0.09%
1 week-1.10%
Current month-4.58%
1 month-4.58%
3 months-7.01%
6 months+6.38%
Current year-2.42%
More quotes
1 week
1 153.00
Extreme 1153
1 179.00
1 month
1 149.00
Extreme 1149
1 235.00
Current year
1 149.00
Extreme 1149
1 344.00
1 year
980.00
Extreme 980
1 344.00
3 years
914.00
Extreme 914
1 344.00
5 years
782.00
Extreme 782
1 548.00
10 years
497.50
Extreme 497.5
1 884.00
More quotes
Managers TitleAgeSince
President 63 01/13/01
Chief Administrative Officer 64 01/15/01
Director/Board Member 48 01/13/01
Members of the board TitleAgeSince
President 63 01/13/01
Director/Board Member 64 01/13/01
Chief Administrative Officer 64 01/15/01
More insiders
Date Price Change Volume
26/24/26 1,167 +0.09% 38,400
25/24/25 1,166 -0.93% 15,100
24/24/24 1,177 +0.51% 28,500
23/24/23 1,171 -0.76% 15,500

Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST

More quotes
WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.
Calendar
More about the company